What is the role of radiotracers in PET imaging?

• A. To provide structural images of tissues
• B. To highlight metabolic activity
• C. To enhance the imaging speed
• D. To mask certain tissues from imaging

Answer: (B)

Radiotracers play a critical role in PET imaging by highlighting metabolic activity within tissues. These substances are designed to emit positrons after being administered to a patient, which then interact with electrons in the body, leading to the production of gamma rays that can be detected by the PET scanner.

The functionality of radiotracers is predicated on their ability to mimic naturally occurring compounds in the body, thereby allowing for a specific visualization of biological processes. For instance, fluorodeoxyglucose (FDG), a commonly used radiotracer, is similar to glucose and is taken up by cells that have high metabolic rates, such as cancer cells. This selective uptake enables clinicians to identify areas of abnormal metabolic activity, aiding in the diagnosis and monitoring of conditions like cancers, neurological disorders, and cardiovascular diseases.

In contrast, options related to providing structural images, enhancing imaging speed, or masking tissues do not accurately represent the primary function of radiotracers in PET imaging. Structural imaging is typically achieved through modalities like CT or MRI, which focus on anatomical details rather than metabolic functions. Enhancing imaging speed is more associated with technology improvements in scanners rather than the role of radiotracers. Masking tissues would negate the purpose of assessing metabolic activity